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Background/aim: Limited research has focused explicitly on the association between neonatal jaundice and autism spectrum disorder
(ASD), and inconclusive evidence exists in the literature within this framework. This study aimed specifically to investigate whether
neonatal jaundice is a potential risk factor for ASD and whether there is a connection between the types of neonatal jaundice and the
severity of ASD.
Materials and method: This study involved 119 children with ASD [90 males (75.6%), 29 females (24.4%), mean age: 45.39 ± 11.29
months] and 133 healthy controls [100 males (75.2%), 33 females (24.8%), mean age: 46.92 ± 11.42 months]. Psychiatric disorders were
diagnosed through the Diagnostic and Statistical Manual of Mental Disorders criteria. Childhood Autism Rating Scale (CARS) was
used to assess the screening and diagnosis of autism. A specially prepared personal information sheet was employed to investigate sociodemographic characteristics and birth and clinical histories.
Results: The rate of the history of jaundice and pathological jaundice requiring hospitalization and phototherapy were significantly
higher in the ASD group compared to the controls. CARS total score and the mean scores of nearly all items were statistically higher in
children with a history of pathological jaundice than those with a history of physiological jaundice.
Conclusion: Neonatal jaundice, depends on its severity, seems to be one of the possible biological factors associated with subsequent
development of and the severity of ASD. Establishing a causal relationship between neonatal jaundice and ASD by more comprehensive
studies may contribute to alleviating of the severity of ASD for individuals at risk.
Key words: Newborn, autism spectrum disorder, neonatal jaundice, phototherapy

1. Introduction
Autism spectrum disorder (ASD) is a group of
neurodevelopmental
disorders
characterized
by
impairments in social communication and interaction,
restricted and repetitive patterns of behaviors that can
persist throughout life [1]. Although many risk factors are
proposed, unfortunately, the specific causes of ASD still
remain to be elucidated, and environmental and/or genetic
factors are among the main contributing factors [2]. In
fact, there is strong evidence that perinatal and obstetric
events, which are among the investigated biological and
environmental risk factors, are involved in the pathogenesis
of ASD. Previous studies have emphasized the importance
of prematurity, cesarean delivery, low Apgar score, low
birth weight, and hypoxia among perinatal risk factors
[2,3]. However, researchers investigating the relationship of
perinatal risk factors and autism phenotypes have stressed
that many of these factors are not the predominant cause

even though they are implicated in autism risk and form
part of the epiphenomena of genetic autism disposition
[3,4].
Neonatal jaundice is one of the perinatal events that
may play a potential risk factor for autism. Neonatal
jaundice is one of the most prevalent clinical conditions,
with being observed in approximately 60% of term and
80% of preterm neonates in the first week of life and a
normal transitional phenomenon that typically resolves
without any treatment for most neonates. However, it is
also the leading reason for newborn hospital readmissions
worldwide [5]. Hyperbilirubinemia in neonates has been
classified as physiological and pathological jaundice
[6]. The most common causes of pathological jaundice
in the neonatal period are hemolytic jaundice, ABO
incompatibility, rhesus incompatibility, G6PD deficiency,
dehydration due to lack of proper feeding, breast milk
jaundice, cephal hematoma, and polycythemia [7].
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Actually, unconjugated bilirubin is beneficial at a low level.
It functions as a potent antioxidant agent, while, at higher
concentrations, it can cross the intact blood-brain barrier
and be neurotoxic in the developing brain of newborns
[8–10]. Therefore, unconjugated hyperbilirubinemia
in the neonatal period is of concern since it can be
related to lifelong sequelae and poor developmental
and neurocognitive outcomes, including cerebral palsy,
intellectual disability, brain dysfunction, attention deficit
hyperactivity disorder, and several impairments of
language and communication similar to ASD [8,11,12].
Previous studies exploring the relationship between
the history of neonatal jaundice and ASD have produced
conflicting results. While some studies have indicated that
infants who developed neonatal jaundice are subsequently
at risk of ASD [13–18), others have failed to find any
significant association [19–21]. Moreover, limited research
has focused mainly on the association between the history
of neonatal jaundice and ASD. Since there is no conclusive
data about the relationship between previous neonatal
jaundice and the development of ASD in childhood, we
thought this might be a relevant risk factor for ASD. The aim
of current study was to assess the risk of autism spectrum
disorder in children with a history of hospitalization for
neonatal jaundice.
2.Material and methods
2.1.Participants
This cross-sectional study was carried out in 119 children
with ASD [90 males (75.6%), 29 females (24.4%) with a
mean age 45.39±11.29 months] and 133 healthy controls
[100 males (75.2%), 33 females (24.8%) with a mean age
46.92±11.42 months] who matched for sex, age, and sociocultural characteristics with the ASD group. Children with
ASD admitted to the Child and Adolescent Psychiatry
Outpatient Clinic were consecutively enrolled in the study.
ASD was the primary diagnosis and the main reason for
seeking treatment in the patient group. The control group
was randomly recruited from healthy-normal children
who applied to the general pediatric outpatient clinics.
Pregnant women who are hospitalized for systemic
infections and antibiotic treatment were considered
as having severe infections during pregnancy. Seizure
comorbidity was diagnosed in cases in which antiepileptic
therapy was initiated by pediatric neurology. In this study,
pathological jaundice was defined as hyperbilirubinemia
requiring hospitalization for phototherapy at least 24 h, as
per relevant national guidelines [7]. However, if a patient
had had neonatal jaundice without requiring phototherapy
on follow-up, it was considered to have physiological
jaundice. Exclusion criteria were the history of stay in a
neonatal intensive care unit, syndromic children, children
with a history of bilirubin encephalopathy requiring
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exchange transfusion in the neonatal period, children with
known chromosomal abnormalities, congenital anomalies,
children with developmental delays or disorders due to
other causes than ASD, and missing data on neonatal
jaundice; children with adverse conditions such as extreme
poverty and severe parental psychosocial deprivation; and
macrosomic (n = 9), postterm (n = 8) cases.
Each participant and his/her parents underwent a
psychiatric examination based on the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition [1].
The study was carried out according to the Declaration
of Helsinki and Good Clinical Practice procedures
principles and approved by the local Ethics Committee of
the Medical Faculty of the Sivas Cumhuriyet University
(Date: 11.12.2019, No: 2019-12/20). The study’s aim and
procedure were explained verbally and written, and verbal
informed consent was obtained for each child.
2.2.Data collection tools
2.2.1.Personal information form
The clinical data were collected as participants’ sociodemographic characteristics (age, sex, place of residence,
family characteristics, etc.) and clinical data (participants’
prenatal/perinatal/neonatal history, health, and disease
status, features of autism and neonatal jaundice, etc.)
using a questionnaire specifically designed by the
researchers. The diagnosis of neonatal jaundice was
performed through information obtained from the
parental interview and categorized into two groups as
physiological and pathological jaundice. Children who
were evaluated by pediatric psychiatry between the ages
of 2 and 6 and diagnosed with autism spectrum disorder
were also divided into two groups based on the history of
physiological or pathological jaundice [7].
2.2.2.Childhood Autism Rating Scale (CARS)
CARS is a well-established instrument for the screening
and diagnosis of autism. It consists of 15 items, which
are scored on a 7-point Likert scale. The examiner/
clinician assigns a score of 1 to 4 for each item: score 1
indicates behavior appropriate for age level, whilescore
2 shows mild, score 3shows moderate, score 4 shows
severe deviance concerning normal behavior for age level,
respectively. The items are “relating to people”, “imitative
behavior,” “emotional response”, “body use”, “object
use”, “adaptation to change”, “visual response”, “listening
response”, “perceptive response”, “fear or anxiety”, “verbal
communication”, “nonverbal communication”, “activity
level”, “level and consistency of intellective relations”, and
“general impressions”. A total score of ≥30 points indicates
the presence of autism. The interval from 30 to 36.5 points
describes mild to moderate autism, and scores of 37–60
define severe autism [22]. The scale’s validity and reliability
have been demonstrated in Turkish children by Sucuoglu
et al. [23].
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2.3.Statistical analysis
SPSS Statistics version 23 was used for statistical analysis.
Kolmogorov–Smirnov test was performed to examine
the distribution of data. The numerical and categorical
data were presented as mean ± standard deviation (SD),
number (n), median (min-max), and percentage (%) as
appropriate. Potential risk factors associated with ASD
were identified using univariate analysis. Categorical
variables were compared using the chi-square or Fisher’s
exact when appropriate, and continuous parametric
variables were analyzed by the Student’s t-test or the Mann–
Whitney test for continuous nonparametric variables.
The variables with 2-tailed p-value of less than 0.05 in
univariate analysis were included in a multivariate logistic
regression model (stepwise) to evaluate the odds ratios
and 95% confidence intervals to calculate the strength of
any association. A p-value of less than 0.05 was considered
statistically significant.
3.Results
3.1.Socio-demographic and familial characteristics of
the sample.
A total of 252 children, 119 with ASD and 133 controls,
participated in this study. The ASD group and the control
group did not differ significantly in terms of age, sex, the
place of residence, family income level, parental education
level, parental consanguinity, and maternal and paternal age
at pregnancy (all p values >0.05). There was no significant
difference between groups for the number of siblings (p =
0.387), but the proportion of being the first-born child was
significantly higher in the ASD group (47.9% vs. 33.8%,
respectively, p = 0.023). Besides, the presence of family
history for ASD (39.5% vs. 6%, respectively, p < 0.001) was
significantly higher in the ASD group than in the control
group. The socio-demographic and familial characteristics
are given in Table 1.
3.2.Maternal characteristics of participants.
Threatened miscarriage, preeclampsia, gestational diabetes,
and other endocrine problems during pregnancy, ABO
and/or Rh incompatibility, excessive tea and/or coffee
consumption, radiation exposure, utilization of vitamins,
minerals, and other supplements during pregnancy were
similar between the two groups (all p values >0.05). Alcohol
and/or substance use during pregnancy was not detected in
the study group. On the other hand, the mothers of children
in the ASD group were significantly more nulliparous than
those in the control group (47.9% vs. 33.8%, respectively,
p = 0.023). Also, the rate of smoking and severe infections
during pregnancy was significantly higher in the mothers
of children with ASD than those in the control group (p =
0.025, p = 0.048, respectively). Maternal characteristics of
participants are shown in Table 2.

Table 1. Socio-demographic and familial characteristics of
participants.
n (%)

ASD
(n=119)

Controls
p-value
(n=133)

Age (months)º

45.4±11.3 46.9±11.4 0.271

Gender (male)

90 (75.6) 100 (75.2) 0.935

Place of residence
Urban

82 (68.9) 85 (63.9) 0.402

Rural

37 (31.1) 48 (36.1)

Family income level
The minimum or less

42 (35.3) 41 (30.8) 0.451

Above the minimum wage

77 (64.7) 92 (69.2)

Maternal education level
Primary education and lower

42 (35.3) 46 (34.6) 0.906

Upper primary education

77 (64.7) 87 (65.4)

Paternal education level
Primary education and lower

42 (35.3) 45 (33.8) 0.808

Upper primary education

77 (64.7) 88 (66.2)

Parental consanguinity

28 (23.5) 34 (25.6) 0.708

Number of siblings (n%)
0

25 (21)

1

55 (46.2) 58 (43.6) 0.387

26 (19.5)

2

26 (21.8) 40 (30.1)

≥3

13 (10.9) 9 (6.8)

Maternal age at pregnancy (y)º 29.3±7.4 28.8±5.8 0.611
Paternal age at pregnancy (y)º 32.8±7.8 31.3±5.8 0.249
Family history of ASD

47 (39.5) 8 (6)

<0.001

ASD: Autism Spectrum Disorder, º:mean±SD, SD: Standard
Deviation.

3.3.Perinatal and natal characteristics and some clinical
features of participants
The use of vacuum-forceps was not detected in any of
the cases. Children with ASD had a statistically higher
percentage of being delivered by cesarean section (29.4%
vs. 16.5%, p = 0.015). The rate of the history of seizures
was significantly higher in the ASD group (35.3% vs.
3.8%, p < 0.001). The perinatal and natal characteristics of
participants are shown in Table 3.
3.4.Comparison of the jaundice features of the groups
The history of apparent jaundice in the ASD group was
significantly higher than in the control group (55.5% vs.
41.4%, respectively, p = 0.025). Furthermore, the frequency
of jaundice requiring hospitalization and phototherapy
was significantly higher in the ASD group compared to

2659

TUNÇ et al. / Turk J Med Sci
Table 2. Maternal characteristics of participants.
n (%)

ASD
(n = 119)

Controls
(n = 133)

p-value

Nulliparity

57 (47.9)

45 (33.8)

0.023

Threatened miscarriage

29 (24.4)

26 (19.5)

0.355

Preeclampsia

7 (5.9)

8 (6)

0.965

Gestational diabetes

9 (7.6)

4 (3)

0.103

Other endocrine problems other than diabetes during pregnancy

6 (5)

3 (2.3)

0.234

Severe infection in pregnancy

27 (22.7)

16 (12)

0.025

ABO and/or Rh incompatibility

5 (4.2)

4 (3)

0.610

Smoking during pregnancy

34 (28.6)

24 (18)

0.048

Excessive tea and/or coffee consumption during pregnancy

25 (21)

29 (21.8)

0.878

Radiation exposure in pregnancy

6 (5)

6 (4.5)

0.843

Vitamins, minerals, and supplements in pregnancy

93 (78.2)

101 (75.9)

0.677

ASD: Autism Spectrum Disorder
Table 3. Perinatal characteristics and some clinical features of participants.
ASD
(n=119)

Controls
(n=133)

Winter (December-February)

23 (19.3)

31 (23.3)

Spring (March-May)

29 (24.4)

36 (27.1)

Summer (June-August)

45 (37.8)

32 (24.1)

Autumn (September-November)

22 (18.5)

34 (25.6)

Vaginal delivery

84 (70.6)

111 (83.5)

Cesarean section

35 (29.4)

22 (16.5)

Preterm (34-37 weeks)

21 (17.6)

15 (11.3)

Term (≥37 weeks)

98 (82.4)

118 (88.7)

<2500 g

19 (16)

15 (11.3)

≥2500 g

100 (84)

118 (88.7)

Hospital

112 (94.1)

125 (94)

Others (house, car, etc.)

7 (5.9)

8 (6)

Birth complication

14 (11.8)

8 (6)

0.106

Seizure/convulsion history

42 (35.3)

5 (3.8)

<0.001

n (%)

p-value

Season of birth
0.114

Birth type
0.015

Gestational age at birth
0.149

Birth weight
0.277

Birthplace
0.965

ASD: Autism Spectrum Disorder.

the controls (25.8% vs. 10.9%, respectively, p = 0.038). In
contrast, the percentage of exchange transfusion did not
differ between the groups (p = 0.346). The data on the
history of jaundice are given in Table 4.
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3.5.Multivariate analyses of variables associated with
autism spectrum disorder
Univariate analyses of variables associated with the risk
of development of ASD include a positive family history
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Table 4. Comparison of the jaundice features of participants.
n(%)

ASD
(n=119)

Controls
(n=133)

p-value

History of jaundice

66 (55.5)

55 (41.4)

0.025

Physiological

49 (74.2)

49 (89.1)

0.038

Pathological

17 (25.8)

6 (10.9)

3 (2.5)

1 (0.8)

Jaundice types

Exchange transfusion

0.346

ASD: Autism Spectrum Disorder.

of autism, nulliparity, smoking during pregnancy, the
experience of severe infection during pregnancy, delivery
by cesarean section, history of neonatal jaundice, especially
pathological jaundice, and the history of seizures.
When these factors were placed into logistic regression
analysis, it was found that the presence of positive family
history for autism and the history of seizures were each
independently associated with the risk of development of
ASD in childhood (Table 5).
3.6.Comparison of clinical variables and CARS scores
according to the type of jaundice
The presence of intellectual disability was not significantly
affected by physiological or pathological jaundice types
(p = 0.394). Still, the children with pathological jaundice
had a substantially higher neonatal seizure history than
the children with physiological jaundice (p < 0.001). As
for the scores of the CARS scale according to the types
of jaundice, CARS total score and the mean scores of all
items except “fear or anxiety” in children with a history
of pathological jaundice were statistically higher than the
scores of children with a history of physiological jaundice
(all p values <0.05). Data on the CARS scores by types of
jaundice are shown in Table 6.

4.Discussion
Given the effect of perinatal events on the developing
brain, the current study aimed to assess whether neonatal
jaundice may play a role in the development or the severity
of childhood autism. The findings indicated that children
with ASD have a significantly higher history of neonatal
jaundice, especially pathological one, which also seems
to affect the severity of the disease (higher CARS total
score). However, it was found that neonatal jaundice is
not independently a risk factor for ASD. On the other
hand, the presence of positive family history for autism
and the history of seizures seem to be associated with the
development of ASD.
Autism spectrum disorder is a heterogeneous
disorder, and the specific cause of most cases of ASD
remains unknown. However, a combination of genetic,
developmental, and environmental factors are emphasized
in its etiology [2,3,24,25]. As consistent with many
previous studies, the presence of positive family history for
autism emphasizes heritability of the disease, indicating
the relevance of genetic factors in the pathogenesis.
Numerous gene variations, which thought to affect the
risk of developing ASD, have been reported, and most of
them can interact with environmental factors to influence
development in ways that cause to ASD. Although
environmental factors are still poorly understood,
numerous studies have identified some prenatal, natal, and
postnatal risk factors, which have potential to contribute
to cerebellar injury, abnormal brain development in ASD
[2]. In general, the risk factors such as maternal mental
and/or medical illnesses, younger maternal age, maternal
age of >40 years old, birth complications, low birth weight,
cesarean section, a low 5-min Apgar score, neonatal
jaundice, smoking during pregnancy, and nulliparity have
been proposed as drivers of increased risk [17,26]. Given
that unconjugated hyperbilirubinemia occurs in varying
degrees in newborn infants, especially in premature

Table 5. Multivariate analyses of variables associated with autism spectrum disorder.

Variable

Odds ratio

Nulliparity

95% Confidence Interval
lower

upper

p

1.56

0.66

3.66

0.308

Maternal smoking during pregnancy

2.38

0.92

6.18

0.074

Positive family history for autism

3.78

1.29

11.1

0.015

Cesarean delivery

1.59

0.64

3.99

0.322

The history of seizure

6.05

1.67

21.9

0.006

Neonatal jaundice

1.21

0.34

4.33

0.769

Severe infection in pregnancy

2.43

0.76

7.77

0.134
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Table 6. Comparison of clinical variables and CARS scores by types of jaundice in participants.
mean ± SD

Physiological
(n = 49)

Pathological
(n = 17)

p-value

Presence of intellectual disabilityº

32 (65.3)

13 (76.5)

0.394

Seizure/convulsion historyº

17 (17.3)

14 (60.9)

<0.001

CARS-Relating to people

2.4 ± 1.2

3.06 ± 1.11

0.007

CARS-Imitative behavior

1.9 ± 1.0

2.34 ± 0.95

0.043

CARS-Emotional response

1.9 ± 1.0

2.58 ± 1.05

0.008

CARS-Body use

1.9 ± 0.8

2.30 ± 0.79

0.029

CARS-Object use

2.0 ± 0.8

2.43 ± 0.82

0.022

CARS-Adaptation to change

1.7 ± 1.5

2.13 ± 0.82

0.010

CARS-Visual response

1.9 ± 1.0

2.58 ± 1.05

0.010

CARS-Listening response

2.5 ± 0.5

2.82 ± 0.98

0.010

CARS-Perceptive response

1.5 ± 0.6

1.93 ± 0.77

0.008

CARS-Fear or anxiety

1.9 ± 0.7

1.89 ± 0.75

0.822

CARS-Verbal communication

2.6 ± 1.1

3.23 ± 1.00

0.006

CARS-Non-verbal communication

2.3 ± 1.3

3.00 ± 1.22

0.007

CARS-Activity level

2.4 ± 0.8

2.82 ± 0.96

0.036

CARS-Level and consistency of intellective relations

1.8 ± 0.9

2.65 ± 1.13

0.001

CARS-General impressions

2.1 ± 1.1

2.91 ± 1.18

0.001

CARS-Total score

30.3 ± 12.7

38.58 ± 12.77

0.003

CARS: Childhood Autism Rating Scale, º: n (%), SD: Standard Deviation.

infants, during the first weeks of life, and having the
potential to cause to cerebellar injury, hyperbilirubinemia
has been questioned as one possible biological factor
associated with subsequent development of ASD [17].
Metaanalyses have demonstrated that neonatal jaundice
may be associated with ASD [16,17]. In fact, previous
studies have generally together addressed environmental
risk factors of autism; few studies have specifically
investigated neonatal jaundice’s role on the risk of ASD.
However, relevant research has resulted in inconsistent
findings. Some studies demonstrated that neonatal
jaundice increased the risk of ASD [12–18,27], whereas
others did not [19–21]. A recent population-based study
objecting to investigate long-term neurodevelopmental
outcomes of significant neonatal jaundice reported a
1.5 to 2- times greater risk for ASD than the reference
cohort [28]. Additionally, some studies have investigated
premature (<37 weeks gestational age) and term infants
with neonatal jaundice separately in terms of ASD risk and
found a significant positive association in term infants but
not in premature infants [13,29,30]. However, in contrast
to those studies, it has been expected that premature
infants would be more vulnerable to neurotoxic effects
of bilirubin, and, therefore, it has been suggested that the
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measurements of bilirubin used by other methods may
be better predictors for neurotoxicity in preterm infants.
Additionally, contradictory findings in those studies
may be caused by the studies’ methodology, such as the
source of cases, the criteria used to identify both neonatal
jaundice and ASD, designs of the studies, the age-group
included, sex, or socio-demographic status. In the study
presented here, because of that many premature infants
experience intensive care support and may be exposed to
many detrimental conditions during intensive care period,
which most parents can’t know or remember, the patients
with those criteria were not included to keep minimizing
bias.
In this study, it was revealed that the rate of every
degree of neonatal jaundice, even physiological one,
was significantly higher in the ASD group, suggesting
a potential relationship between ASD and neonatal
jaundice. Additionally, this study showed that the history
of pathological jaundice was associated with higher CARS
score, which represents clinical severity of the disease.
Despite this association has been reported previously
[14,26,27,31], the underlying mechanisms have not
been clarified yet. Abnormal auditory evoked responses
and impaired communication may be observed in both
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ASD and bilirubin-induced neurotoxicity, showing a
potential temporal relationship [17]. On the other hand,
many of the genes associated with ASD are also involved
in the development of the brain [32], and, therefore,
some proteins controlled by those genes may make the
production, growth, or organization of neurons more
vulnerable to neurotoxicity of bilirubin.
The potential brain damage due to hyperbilirubinemia
has been suggested as the underlying mechanism
resulting in ASD [15]. As it is well known, even though
hyperbilirubinemia is almost always benign, it may also
result in bilirubin-induced neurologic dysfunction at
excessive levels. It can impact brain development, cognitive
functions, synaptic plasticity, learning, and memory.
The brain’s regions susceptible to bilirubin toxicity
are the globus pallidus, hippocampus, peripheral and
central auditory pathways, cerebellum, and subthalamic
nuclear bodies [8,10]. Previous studies have proposed
that crucial processes such as neurogenesis, myelination,
and synaptogenesis during early brain development at
these brain regions were negatively affected by bilirubin
[10]. Many of these regions are also closely related to the
pathogenesis of ASD [33,34]. It is well known that athetoid
cerebral palsy, neuromotor abnormalities, neurobehavioral
symptoms, intellectual disability, paralysis of upward
gaze, sensorineural, audiological, and visual-motor
dysfunctions, speech and communication impairments
observed in kernicterus are similar to ASD [8,11,12,21,35].
However, these findings are the tip of the iceberg, and
bilirubin-induced neurological dysfunction may also
occur without characteristic clinical manifestations of
apparent kernicterus [17,36]. Some authors have proposed
that phototherapy might trigger the pathophysiological
mechanisms of ASD through implicated in DNA damage
and/or affecting cytokine levels and oxidative stress [37–
39]. However, further researches should be attempted to
establish a causal relationship between neonatal jaundice
and ASD. If there is any impact of neonatal jaundice on
the developing ASD, the prevention and early treatment of
jaundice may be a promising step in reducing development
or severity of ASD in individuals at risk, such as family
members of a person with autism.
The present study findings demonstrate that family
history of autism, nulliparity, maternal smoking, and
severe infection during pregnancy, delivery by cesarean
section, and the history of neonatal jaundice, in particular,
pathological jaundice, and seizure are risk factors for ASD.
Autism is more common in males, and, in this study, male
sex made up three-quarters of patients in the ASD group.
Because of age and sex-matched control group selection,
male sex was not found as a risk factor in the statistical
analyses. Multivariate analyses revealed that the presence
of a family history of autism and seizure are independently

associated with ASD. Epilepsy and autism may co-occur
with the frequency of up to 20% of children with either
disorder, suggesting that the two entities share underlying
pathology. Despite it has not been clarified whether
epilepsy contributes to ASD or is a consequence of ASD,
growing evidence suggests that ASD is not the result of
inadequately treated epilepsy [40]. The prevalence of ASD
was higher in children with a history of seizures in the first
year of life compared to the general population [41]. It has
been reported that autistic children with epilepsy have
more severe autism symptoms, and conversely, the risk of
epilepsy is increased in ASD patients with higher scores
[42]. Despite both diseases are etiologically heterogeneous,
a possible relationship between epilepsy and ASD may
be the result of abnormal brain development caused by
neurobiological antecedent (structural or developmental
lesions, genetic defects, or environmental insults) or
abnormal neuronal plasticity [43]. Early detection and
treatment of seizures may prevent severe symptoms of
ASD.
Given that most of the previous studies were based
on ICD codes or insurance databases that might reveal
treatment codes inconsistent with a definitive diagnosis,
the strength of this study is the study population, which
was selected from a relatively larger clinical sample. This
study replicates and extends the previous studies’ results
in children with ASD and puts some additional data on
the relationship between neonatal jaundice and ASD.
However, there are some limitations of this study. First, the
study’s cross-sectional design and the sample enrollment
from a single hospital prevent the generalization of
the results and the determination of causality. Second,
maternal interviews were used for the ascertainment
method of neonatal jaundice. The diagnosis of jaundice
was not confirmed by using the medical records of
children; hence, the relationship between blood bilirubin
concentrations and ASD was based on clinical jaundice.
Further, “maternal interviews” may be prone to recall bias.
Third, given the retrospective nature of the study, the data
may not have included some necessary variables (such as
the cause of the seizure, effects of drug or heavy metals,
viral infections, genetics factors), and this might lead to
the difficulty in evaluating temporal relationships between
events. Finally, one of the limitations of the study is that it
was not known exactly how many days of hospitalization
for phototherapy in the neonatal period.
5.Conclusion
This study showed that the rate of neonatal jaundice is
higher in the patients subsequently suffering from ASD,
and additionally it seems that jaundice requiring treatment
affects the severity of ASD. Therefore, the prevention and
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early treatment of neonatal jaundice may be a promising
step in reducing development or severity of ASD in
individuals at risk. The presence of family history for
ASD and the history of seizures seem to be independent
risk factors for ASD. So, early detection and treatment
of seizures appear to be important for minimizing the
severity of ASD, which may develop later. However, more
comprehensive, prospective studies with the objective
of establishing a causal relationship between neonatal
jaundice and ASD, as well as seizure and ASD, may provide
evidence-based treatment strategies for patients with ASD.
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